Nordea Investment Management AB Trims Stock Position in Masimo Corporation $MASI

Nordea Investment Management AB lessened its stake in Masimo Corporation (NASDAQ:MASIFree Report) by 12.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 28,319 shares of the medical equipment provider’s stock after selling 4,180 shares during the period. Nordea Investment Management AB’s holdings in Masimo were worth $3,690,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after acquiring an additional 66 shares in the last quarter. Clearstead Advisors LLC lifted its holdings in Masimo by 18.4% in the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 73 shares during the period. Orion Porfolio Solutions LLC boosted its position in Masimo by 2.2% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock worth $819,000 after purchasing an additional 104 shares in the last quarter. MAI Capital Management grew its stake in shares of Masimo by 176.7% during the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 129 shares during the period. Finally, Smartleaf Asset Management LLC grew its stake in shares of Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 136 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Up 0.1%

Masimo stock opened at $177.11 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47. The stock has a market capitalization of $9.51 billion, a PE ratio of -16.80, a price-to-earnings-growth ratio of 1.79 and a beta of 1.21. The business has a 50 day simple moving average of $159.93 and a 200-day simple moving average of $148.32. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $179.00.

Analysts Set New Price Targets

Several equities analysts recently issued reports on MASI shares. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Raymond James Financial lowered shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a research report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Eight research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $181.17.

Read Our Latest Report on MASI

Masimo Company Profile

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Recommended Stories

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASIFree Report).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.